IMMX   $9.11  -5.89% Market Closed After Close 9.5 4.28%

Immix Biopharma, Inc.
Total Cash 23.98M
totalCashPerShare 0.873
EBITDA -20.18M
Total Debt 1.09M
quickRatio 6.652
currentRatio 7.004
Total Revenue
debtToEquity 4.567
Revenue/Share
ROA -0.56845003
ROE -1.03806
grossProfits
freeCashflow -8.69M
operatingCashflow -14.85M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue 21.04M
forwardPE -2.909091
floatShares 14.50M
sharesOutstanding 27.45M
sharesShort 450.50K
sharesShortPriorMonth 479.69K
dateShortInterest
sharesPercentSharesOut 0.02%
heldPercentInsiders 0.40%
heldPercentInstitutions 0.18%
Short Ratio help_outline 3.01%
shortPercentOfFloat 0.05%
impliedSharesOutstanding
bookValue 0.871
Price To Book help_outline 1.84
earningsQuarterlyGrowth
netIncomeToCommon -19.02M
trailingEps -0.83%
forwardEps -0.55%
enterpriseToEbitda -1.04
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.16 3Q 2024
institutionsCount 36
lastUpdated Nov. 7, 2024, 10:57 a.m.